Navigation Links
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Date:7/26/2013

BOSTON, July 26, 2013 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the appointment of Gino Santini to its Board of Directors. Mr. Santini is a former top executive with Eli Lilly and Company, and is globally respected in the industry after nearly three decades of global pharmaceutical experience. Mr. Santini now will help guide Intarcia through the final stages of development, partnering, and early commercialization of its lead therapeutic candidate, ITCA 650 (a breakthrough once- or twice-yearly GLP-1 for type 2 diabetes that is currently in Phase 3 clinical trials). Mr. Santini will also have significant input on the continuing efforts to build out the Company's product pipeline.

"As we look to continue to strengthen our Board, Gino stood out as an exceptional candidate and proven leader in the industry whose qualifications are well suited to help us meet all our opportunities to advance our Company," said Kurt Graves, Chairman, President and CEO of Intarcia. "We are delighted to welcome Gino to the Intarcia Board of Directors, and we look forward to gaining the benefit of his extensive global operating experience, all of his business development acumen, and his in-depth knowledge and insights in the diabetes marketplace."

Gino Santini began his distinguished career at Lilly as a Financial Planning Associate in Italy in 1983 and subsequently served in roles of increasing responsibility, including: Pharmaceutical Director in Belgium, General Manager in Mexico City, Area Director of Latin America, President of Lilly's women's health business, and President of U.S. Operations. In his final role as Senior Vice President of Corporate Strategy and Business Development and a member o
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
3. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 Actavis plc (NYSE: ... offering of $21 billion aggregate principal amount of senior ... offering to be issued by its indirect wholly-owned subsidiary, ... other subsidiaries (the "Notes"), as follows: Logo ... Notes* , $500,000,000 , Due 2016 , ...
(Date:3/3/2015)... 2015  Cumberland Pharmaceuticals Inc. (NASDAQ: ... hospital acute care and gastroenterology, today announced achievement ... include top-line results from the Company,s Hepatoren Phase ... Application (sNDA) with pediatric data for Caldolor and ... II clinical trial. "The sNDA for ...
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/tbjpmj/blister_packaging ) ... Market in the US 2015-2019" report to their ... the US to grow at a CAGR of 6.11% ... form of high-visibility packaging that uses pre-formed plastic packs ... a base layer, made either of plastic or aluminum, ...
Breaking Medicine Technology:Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 2Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 3Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 4Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 5United States Blister Packaging Market 2015-2019 - Growing Demand in Pharmaceuticals Industry with Amcor, Bemis, MeadWestvaco & Sonoco Products Dominating 2
... Oct. 31, 2011 Rock Creek Pharmaceuticals, a wholly owned ... today announced the second presentation of research findings related to ... a Tobacco Alkaloid, Ameliorates Disease in a Mouse Model of ... meeting of the American Thyroid Association in Indian Wells, CA ...
... SYDNEY, Oct. 31, 2011  To successfully irradiate a moving lung ... the tumor from moving or a means to compensate for ... Hospital Cancer Centre (Randwick, New South Wales) chose the second ... for the first time to treat a 75-year-old male patient ...
Cached Medicine Technology:Rock Creek Pharmaceuticals Announces Completion of Medical Conferences on Anatabloc™ Research, Comments on Research Presentation at American Thyroid Association Annual Meeting 2Rock Creek Pharmaceuticals Announces Completion of Medical Conferences on Anatabloc™ Research, Comments on Research Presentation at American Thyroid Association Annual Meeting 3Rock Creek Pharmaceuticals Announces Completion of Medical Conferences on Anatabloc™ Research, Comments on Research Presentation at American Thyroid Association Annual Meeting 4Australia's Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elekta's Advanced 4D Motion Management Technology 2Australia's Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elekta's Advanced 4D Motion Management Technology 3
(Date:3/4/2015)... MILWAUKEE, WI (PRWEB) March 04, 2015 ... dental products distributor announced on Wednesday its strategic partnership ... customers with online tools that will introduce them to ... trends happening in dentistry. , The Dental Exchange ... platform exclusively for the dental industry. Unlike other social ...
(Date:3/4/2015)... Georgia (PRWEB) March 04, 2015 The ... Sleep Awareness Week with World Sleep Awareness Day being ... awareness to the health and financial risks associated with ... support, the Sleep Apnea Treatment Centers of America have ... daily educational articles, they hope will virally inspire conversation ...
(Date:3/4/2015)... A new poll by The ... —“What retirement cost is hardest for you to cover?” ... costs were most difficult, 40% — as those who ... percent said nourishing food, and 4% said transportation, was ... because it illustrates the significance of healthcare costs on ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... a worrisome public health issue worldwide. The rising prevalence ... economic and social burden in both developed and developing ... is projected to rise to 1.5 billion, equating to ... of these patients are forecast to come from the ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 Theme and ... a new title pack for Final Cut Pro X entitled ... animated text presets to any FCPX editors project.” Said Christiana ... the tools needed to add animated font to their FCPX ... drawn text look all within Final Cut Pro X. ProFont ...
Breaking Medicine News(10 mins):Health News:Ada Products Company, Inc. Announces Strategic Partnership with the Dental Exchange 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4Health News:Most Difficult Cost In Retirement? Retirees Evenly Split Between Housing and Healthcare, Says New Poll By The Senior Citizens League 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Announcing a New Title Pack from Pixel Film Studios, ProFont NoteBook for Final Cut Pro X 2
... in the brain of patients suffering from mild cognitive ... MCI to Alzheimer’s disease (AD) dementia//, according to a ... Aging. ,Researchers at Mount Sinai School of ... may be delayed by eliminating plaque causing beta-amyloid peptides ...
... Pasteur, the world's third-largest pharmaceutical firm together with the Public ... trials on an avian flu vaccine, which could be used ... Chotpitayasunondh, a member of the ministry's human avian flu study ... children aged six months to 18 years owing to the ...
... experts have warned that the increasing rate of tuberculosis, ... was controlled among the socially excluded groups. // ... higher among the ,homeless population, drug abusers, HIV patients ... and economic situation in England. ,Unless ...
... take acetaminophen for their aches and pains could be ... the findings of a new study// . ... recommended daily dose of acetaminophen showed abnormalities in blood ... initially they had come across liver damage in patients ...
... dose of radiotherapy may be beneficial in early stage of ... cancer// from progressing to a deadlier form, they reported in ... (DCIS) occurs in the duct cells lining the milk ducts. ... to the ducts and has not spread outside. The usual ...
... taken over as president of the British Medical Association ... quoted from poet laureate Rabindranath Tagore's "Gitanjali", "Where the ... over office. ,Kumar, who was born ... London and the Homerton Hospitals and has a distinguished ...
Cached Medicine News:Health News:Discovery of Elevated Amyloid Peptide levels could lead to Alzheimer’s Preventio 2Health News:Agreement for Joint Trials of Avian Flu Vac cine on Humans 2Health News:Socio-economically Excluded People, more affected by Tuberculosis , 2Health News:Even Normal Doses Of Tylenol Could Damage Liver 2Health News:Indian Origin Woman is the New Head of British Medical Association 2
Inquire...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
Medicine Products: